4.7 Review

Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis

Journal

BLOOD
Volume 138, Issue 23, Pages 2327-2336

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2021011992

Keywords

-

Categories

Funding

  1. National Institutes of Health (National Institute of Diabetes and Digesitive and Kidney Diseases) [R01DK110108]
  2. National Institutes of Health (National Cancer Institute) [R01CA204044, R01CA172408]
  3. National Institutes of Health (National Heart, Lung and Blood Institute) [R01HL141950, R01HL145883, R01HL144712]
  4. Cancer Prevention and Research Institute of Texas [RP200242]
  5. Four Diamonds Fund

Ask authors/readers for more resources

Genome-wide analyses have shown that long noncoding RNAs (lncRNAs) play crucial roles in regulating genome structure and transcription, impacting various biological processes. Aberrant expression of thousands of lncRNAs has been observed in different cancer types, suggesting their involvement in malignant transformation. Despite extensive efforts, the specific functions and molecular mechanisms of lncRNAs remain unclear.
Genome-wide analyses have revealed that long noncoding RNAs (lncRNAs) are not only passive transcription products, but also major regulators of genome structure and transcription. In particular, lncRNAs exert profound effects on various biological processes, such as chromatin structure, transcription, RNA stability and translation, and protein degradation and localization, that depend on their localization and interacting partners. Recent studies have revealed that thousands of lncRNAs are aberrantly expressed in various cancer types, and some are associated with malignant transformation. Despite extensive efforts, the diverse functions of lncRNAs and molecular mechanisms in which they act remain elusive. Many hematological disorders and malignancies primarily result from genetic alterations that lead to the dysregulation of gene regulatory networks required for cellular proliferation and differentiation. Consequently, a growing list of lncRNAs has been reported to be involved in the modulation of hematopoietic gene expression networks and hematopoietic stem and progenitor cell (HSPC) function. Dysregulation of some of these lncRNAs has been attributed to the pathogenesis of hematological malignancies. In this review, we summarize current advances and knowledge of lncRNAs in gene regulation, focusing on recent progress on the role of lncRNAs in CTCF/cohesin-mediated 3-dimensional genome organization and how such genome folding signals, in turn, regulate transcription, HSPC function, and transformation. This knowledge will provide mechanistic and translational insights into HSPC biology and myeloid malignancy pathophysiology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available